CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

lactobacillus crispatus

Cell therapyexperimental

Lactobacillus crispatus is a common, rod-shaped species of genus Lactobacillus and is a lactic acid producing bacterial species located in both the vagina, through vaginal discharge, and the vertebrate gastrointestinal tract. This species commonly found in vaginal microbiome and is thought to be beneficial to health. — Wikipedia

Clinical trial activity

17 trials · 32 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
3
Phase 3
2
Phase 4
0

Earliest trial started Feb 1, 2015 (NCT02744638)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • lactobacillus crispatus
  • lactobacillus crispatus ctv-05

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07266532N/ANov 30, 2025Shenzhen University
NCT07308808Early Phase 1 (Phase 1)Sep 9, 2025Georgetown University, Loyola University
NCT06978907N/AJul 1, 2025Liaquat University of Medical & Health Sciences, University of Insubria
NCT06135974Early Phase 1 (Phase 1)Oct 19, 2023Bill and Melinda Gates Foundation, Centre for the AIDS Programme of Research in South Africa, Harvard University, Ragon Institute of MGH, MIT and Harvard
NCT06802809N/AJan 5, 2022Liaquat University of Medical & Health Sciences, University of Insubria
NCT05022212Phase 2May 10, 2021Aurum Institute, Harvard University, Health Systems Trust, Osel, Inc., University of California, San Francisco, University of Kwa-Zulu Natal
NCT04373512Phase 3May 31, 2020Georgetown University
NCT04307173Phase 1Apr 9, 2020KoBioLabs, Linear Clinical Research, Novotech
NCT04246151Early Phase 1 (Phase 1)Mar 31, 2020Hamilton Health Sciences Corporation
NCT04676503N/ANov 22, 2019NTC srl, Ospedale Santa Maria alle Scotte
NCT04118049N/AOct 30, 2019University of Connecticut, University of Maryland
NCT03992534N/AJul 1, 2019Imperial College London, University of London
NCT03904407N/AJun 1, 2019Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, University of North Carolina at Chapel Hill
NCT03923985N/AMar 21, 2019Instituto Palacios
NCT02766023Phase 2May 31, 2016National Institute of Allergy and Infectious Diseases (NIAID)
NCT03151967Phase 2/Phase 3 (Phase 3)Sep 1, 2015University of Washington
NCT02744638N/AFeb 1, 2015Dairyfem R&D GmbH, University of Kiel, University of Natural Resources and Life Sciences
Showing 17 of 17 trials
Page 1 / 1

Organizations

Research & Development (32)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Georgetown UniversityAcademic/Hospital2222020
Harvard UniversityAcademic/Hospital2122021
Liaquat University of Medical & Health SciencesAcademic/Hospital2212022
University of InsubriaAcademic/Hospital2012022
Aurum InstituteAcademic/Hospital1012021
Bill and Melinda Gates FoundationAcademic/Hospital1012023
Centre for the AIDS Programme of Research in South AfricaGovernment1012023
Dairyfem R&D GmbHFor profit1012015
Hamilton Health Sciences CorporationAcademic/Hospital1112020
Health Systems TrustAcademic/Hospital1012021
Imperial College LondonAcademic/Hospital1112019
Instituto PalaciosAcademic/Hospital1112019
KoBioLabsFor profit1112020
Linear Clinical ResearchFor profit1012020
Loyola UniversityAcademic/Hospital1012025
National Institute of Allergy and Infectious Diseases (NIAID)Government1112016
NovotechFor profit1012020
NTC srlFor profit1112019
Osel, Inc.For profit1112021
Ospedale Santa Maria alle ScotteAcademic/Hospital1012019
32 organizations
Page 1 / 2